Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 13, 2011
N-myc controls proliferation, morphogenesis, and patterning of the inner earElena Domínguez-Frutos, Iris López-Hernández, Victor Vendrell, et al.Cell Reports|November 14, 2024
The immune landscape of murine skeletal muscle regeneration and agingNeuza S Sousa, Marta Bica, Margarida F Brás, et al.Nature Metabolism|September 7, 2019
MANF regulates metabolic and immune homeostasis in ageing and protects against liver damagePedro Sousa-Victor, Joana Neves, Wendy Cedron-Craft, et al.Scientific Reports|July 2, 2016
A novel AhR ligand, 2AI, protects the retina from environmental stressMark A Gutierrez, Sonnet S Davis, Andrew Rosko, et al.Haematologica|March 4, 2017
Cdk6 contributes to cytoskeletal stability in erythroid cellsIris Z Uras, Ruth M Scheicher, Karoline Kollmann, et al.BJU International|July 7, 2025
Natural history of treated and untreated renal oncocytoma: a systematic review and meta-analysisFrancesco Edwards, Jack B Fanshawe, Joana Neves, et al.Molecular Cell|December 1, 2022
POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cellsOndrej Belan, Marie Sebald, Marek Adamowicz, et al.Science Advances|June 12, 2026
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapyGonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacyHelen M R Robinson, Vera Grinkevich, Jayesh B Majithiya, et al.Nature Communications|June 18, 2021
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Helen M R Robinson, Omar Alkhatib, et al.Pageof 7